GEHC * Stock Overview Engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
GE HealthCare Technologies Inc. Competitors Price History & Performance
Summary of share price highs, lows and changes for GE HealthCare Technologies Historical stock prices Current Share Price US$1,803.79 52 Week High US$1,820.00 52 Week Low US$1,310.00 Beta 1.33 1 Month Change 14.67% 3 Month Change 4.33% 1 Year Change 30.99% 3 Year Change n/a 5 Year Change n/a Change since IPO 53.51%
Recent News & Updates
GE HealthCare Unveils Enhanced Voluson Expert Series Women’s Health Ultrasound Systems with Focus on Early Detection and Exam Efficiency Jan 28
High number of new and inexperienced directors Jan 16
High number of new and inexperienced directors Jan 03
Now 22% undervalued after recent price drop Dec 19
High number of new and inexperienced directors Dec 13
GE HealthCare Technologies Inc. to Report Q4, 2024 Results on Feb 13, 2025 Dec 12 See more updates
GE HealthCare Unveils Enhanced Voluson Expert Series Women’s Health Ultrasound Systems with Focus on Early Detection and Exam Efficiency Jan 28
High number of new and inexperienced directors Jan 16
High number of new and inexperienced directors Jan 03
Now 22% undervalued after recent price drop Dec 19
High number of new and inexperienced directors Dec 13
GE HealthCare Technologies Inc. to Report Q4, 2024 Results on Feb 13, 2025 Dec 12
GE HealthCare Technologies Inc. (NasdaqGS:GEHC) agreed to acquire remaining 50% stake in Nihon Medi Physics Co. Ltd from Sumitomo Chemical Company, Limited (TSE:4005). Dec 03 GE Healthcare Highlights New Solutions Including Ai-Enabled Innovations to Drive Precision Care At Rsna 2024
GE HealthCare unveils Pristina Via to streamline technologist workflow and improve patient-centered breast care Nov 26
GE HealthCare Announces Advanced Imaging Innovations for OEC 3D C-arm to Help Improve Precision Care in Practice of Interventional Pulmonology Nov 22
GE HealthCare Technologies Inc. Reiterates Earnings Guidance for the Year 2024 Nov 21
GE Healthcare Announces Publication of Data from A Two-Phase Pilot Study Conducted with Cleveland Clinic in the Peer-Reviewed Journal of Clinical Anesthesia Nov 19
GE HealthCare Receives FDA Clearance for Head-Only SIGNA MAGNUS 3.0T MRI System Nov 13 GE HealthCare Technologies Inc. has completed a Follow-on Equity Offering. GE HealthCare Technologies Inc. has filed a Follow-on Equity Offering. Nov 08
Insider recently sold Mex$1.6m worth of stock Nov 07
GE HealthCare Technologies Inc. Updates Earnings Guidance for the Full Year 2024 Nov 02
Third quarter 2024 earnings released: EPS: US$1.03 (vs US$0.83 in 3Q 2023) Nov 01
GE HealthCare Technologies Inc. Announces Hospital Pulse, the Newest Tile for Its Command Center Software Platform Oct 18
GE HealthCare Introduces Easy-To-Use, Easy-To-Learn, Easy-To-Appoint Versana Premier Multi-Purpose Ultrasound System Oct 14
Upcoming dividend of US$0.03 per share Oct 12
GE Healthcare Accelerates Artificial Intelligence Adoption with New Offering to Advance Enterprise Imaging Oct 10
GE HealthCare Technologies Inc. to Report Q3, 2024 Results on Oct 30, 2024 Oct 08
GE HealthCare Announces Phase I Results for a First-of-its-Kind Macrocyclic Manganese-Based MRI Contrast Agent Oct 07
GE Healthcare Announces FDA Approval of Flyrcado (Flurpiridaz F 18) Injection Pet Radiotracer for Enhanced Diagnosis of Coronary Artery Disease Sep 30
Second quarter dividend of US$0.03 announced Sep 23 GE HealthCare Introduces Elevated Venue Point of Care Ultrasound Solutions and New Tablet-Based Venue Sprint GE HealthCare Technologies Inc. has filed a Follow-on Equity Offering.
Now 21% undervalued Aug 26
GE HealthCare Technologies Inc. Showcases Latest AI-Enhanced Cardiology Solutions to Enable Real-Time Cardiac Imaging and Assessments At the Point of Care At ESC 2024 Aug 26
GE HealthCare Announces the Publication of the MASTER Trial Results in the Peer-Reviewed Journal Anesthesia and Analgesia Aug 21
Insider recently sold Mex$4.2m worth of stock Aug 08
GE Healthcare Technologies Inc. Updates Earnings Guidance for the Year 2024 Aug 01
GE Healthcare Technologies Inc. Updates Earnings Guidance for the Year 2024 Jul 31
GE HealthCare Technologies Inc. to Report Q2, 2024 Results on Jul 31, 2024 Jul 09
First quarter dividend of US$0.03 announced Jul 01
GE HealthCare Technologies Inc. Announces Cash Dividend for Second Quarter of 2024, Payable on August 15, 2024 Jun 26
GE Healthcare Names Adam Holton as Chief People Officer Jun 01
Chief Science & Technology Officer recently sold Mex$4.3m worth of stock May 30
GE HealthCare Unveils SIGNA MAGNUS, an FDA 510(K) Pending Head-Only Magnetic Resonance (MR) Scanner Designed to Explore Advance Advancements in Neuro Science May 06
Insider recently bought Mex$1.7m worth of stock May 03
GE HealthCare Launches New Era of AI-Enhanced, Personalized Oncology Solutions at ESTRO 2024 Congress May 02
First quarter 2024 earnings released: EPS: US$0.82 (vs US$0.41 in 1Q 2023) May 01 GE HealthCare Technologies Inc. Reaffirms Earnings Guidance for the Full Year 2024
High number of new and inexperienced directors Apr 23
GE HealthCare Introduces AI-Enhanced Voluson Signature 20 and 18 Ultrasound Systems to Advance Women's Health Imaging Apr 19
GE HealthCare Technologies Inc. to Report Q1, 2024 Results on Apr 30, 2024 Apr 10 GE HealthCare Technologies Inc., Annual General Meeting, May 21, 2024 Apr 05
GE Healthcare Introduces Caption AI on Vscan Air SL Wireless Handheld Ultrasound System to Help More Clinicians Capture Diagnostic-Quality Cardiac Images Apr 03 GE HealthCare Unveils AI-Enabled Urology Software Feature Prostate Volume Assist
GE HealthCare Technologies Inc. to Feature Latest Technologies in Interventional Radiology Focused on Precision Care At Sir 2024 Mar 22 GE HealthCare Technologies Inc. has filed a Follow-on Equity Offering. Mar 13
GE HealthCare Technologies Inc. has completed a Follow-on Equity Offering in the amount of $1.06925 billion. Feb 17
GE HealthCare Technologies Inc. has filed a Follow-on Equity Offering. Shareholder Returns GEHC * MX Medical Equipment MX Market 7D 0% 0% 0% 1Y 31.0% 0% 0%
See full shareholder returns
Return vs Market: GEHC * exceeded the MX Market which returned -11.3% over the past year.
Price Volatility Is GEHC *'s price volatile compared to industry and market? GEHC * volatility GEHC * Average Weekly Movement n/a Medical Equipment Industry Average Movement 0% Market Average Movement 0% 10% most volatile stocks in MX Market 0% 10% least volatile stocks in MX Market 0%
Stable Share Price: GEHC *'s share price has been volatile over the past 3 months compared to the MX market.
Volatility Over Time: Insufficient data to determine GEHC *'s volatility change over the past year.
About the Company GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women’s health products.
Show more GE HealthCare Technologies Inc. Fundamentals Summary How do GE HealthCare Technologies's earnings and revenue compare to its market cap? GEHC * fundamental statistics Market cap Mex$829.11b Earnings (TTM ) Mex$34.33b Revenue (TTM ) Mex$400.84b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) GEHC * income statement (TTM ) Revenue US$19.56b Cost of Revenue US$11.47b Gross Profit US$8.09b Other Expenses US$6.41b Earnings US$1.68b
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 13, 2025
Earnings per share (EPS) 3.67 Gross Margin 41.34% Net Profit Margin 8.56% Debt/Equity Ratio 121.2%
How did GEHC * perform over the long term?
See historical performance and comparison Dividends
0.2% Current Dividend Yield When do you need to buy GEHC * by to receive an upcoming dividend? GE HealthCare Technologies dividend dates Ex Dividend Date Jan 14 2025 Dividend Pay Date Feb 14 2025 Days until Ex dividend 26 days Days until Dividend pay date 5 days
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2025/02/07 17:33 End of Day Share Price 2025/01/30 00:00 Earnings 2024/09/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github .
Analyst Sources GE HealthCare Technologies Inc. is covered by 27 analysts. 20 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Navann Ty Dietschi BNP Paribas Exane Craig Bijou BofA Global Research Michael Gorman BTIG
Show 24 more analysts 